AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 284: E424-E434, 2003. First published October 22, 2002; doi:10.1152/ajpendo.00382.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/2/E424    most recent
00382.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walgren, J. L. E.
Right arrow Articles by Buse, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walgren, J. L. E.
Right arrow Articles by Buse, M. G.
Vol. 284, Issue 2, E424-E434, February 2003

High glucose and insulin promote O-GlcNAc modification of proteins, including alpha -tubulin

Jennie L. E. Walgren1,2, Timothy S. Vincent3, Kevin L. Schey2, and Maria G. Buse1,4

1 Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, and 2 Departments of Pharmacology, 3 Pathology, and 4 Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425

Increased flux through the hexosamine biosynthesis pathway has been implicated in the development of glucose-induced insulin resistance and may promote the modification of certain proteins with O-linked N-acetylglucosamine (O-GlcNAc). L6 myotubes (a model of skeletal muscle) were incubated for 18 h in 5 or 25 mM glucose with or without 10 nM insulin. As assessed by immunoblotting with an O-GlcNAc-specific antibody, high glucose and/or insulin enhanced O-GlcNAcylation of numerous proteins, including the transcription factor Sp1, a known substrate for this modification. To identify novel proteins that may be O-GlcNAc modified in a glucose concentration/insulin-responsive manner, total cell membranes were separated by one- or two-dimensional gel electrophoresis. Selected O-GlcNAcylated proteins were identified by mass spectrometry (MS) analysis. MS sequencing of tryptic peptides identified member(s) of the heat shock protein 70 (HSP70) family and rat alpha -tubulin. Immunoprecipitation/immunoblot studies demonstrated several HSP70 isoforms and/or posttranslational modifications, some with selectively enhanced O-GlcNAcylation following exposure to high glucose plus insulin. In conclusion, in L6 myotubes, Sp1, membrane-associated HSP70, and alpha -tubulin are O-GlcNAcylated; the modification is markedly enhanced by sustained increased glucose flux.

insulin resistance; L6 myotubes; O-linked N-acetylglucosamine; heat shock protein 70


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Hu, J. Suarez, E. Fricovsky, H. Wang, B. T. Scott, S. A. Trauger, W. Han, Y. Hu, M. O. Oyeleye, and W. H. Dillmann
Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose
J. Biol. Chem., January 2, 2009; 284(1): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Guinez, A.-M. Mir, V. Dehennaut, R. Cacan, A. Harduin-Lepers, J.-C. Michalski, and T. Lefebvre
Protein ubiquitination is modulated by O-GlcNAc glycosylation
FASEB J, August 1, 2008; 22(8): 2901 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. J. Copeland, J. W. Bullen, and G. W. Hart
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E17 - E28.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Noach, Y. Segev, I. Levi, S. Segal, and E. Priel
Modification of Topoisomerase I Activity by Glucose and by O-Glcnacylation of the Enzyme Protein
Glycobiology, December 1, 2007; 17(12): 1357 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fulop, Z. Zhang, R. B. Marchase, and J. C. Chatham
Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2227 - H2236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. P. R. Rao, R. Wassell, M. A. Shaw, and K. Sharma
Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1182 - F1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. Champattanachai, R. B. Marchase, and J. C. Chatham
Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C178 - C187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Bertrand, A. Ginion, C. Beauloye, A. D. Hebert, B. Guigas, L. Hue, and J.-L. Vanoverschelde
AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H239 - H250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Buse
Hexosamines, insulin resistance, and the complications of diabetes: current status
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Nagy, V. Champattanachai, R. B. Marchase, and J. C. Chatham
Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C57 - C65.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. T. Kneass and R. B. Marchase
Neutrophils Exhibit Rapid Agonist-induced Increases in Protein-associated O-GlcNAc
J. Biol. Chem., October 29, 2004; 279(44): 45759 - 45765.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. B. Arias, J. Kim, and G. D. Cartee
Prolonged Incubation in PUGNAc Results in Increased Protein O-Linked Glycosylation and Insulin Resistance in Rat Skeletal Muscle
Diabetes, April 1, 2004; 53(4): 921 - 930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online